All Stories

  1. Principal components analysis of agitation outcomes in Alzheimer's disease
  2. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study
  3. Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History
  4. Solutions for quantifying P-value uncertainty and replication power
  5. Genetic Variation in theIL-6andHLA-DQB1Genes Is Associated with Spontaneous Clearance of Hepatitis C Virus Infection
  6. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study
  7. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial
  8. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications
  9. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2
  10. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
  11. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies
  12. Neurocognitive performance in family-based and case-control studies of schizophrenia
  13. Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1)
  14. Attention/vigilance in schizophrenia: Performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)
  15. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: Comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)
  16. Findings from the National Memory Screening Day Program
  17. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region
  18. The STEP model: Characterizing simultaneous time effects on practice for flight simulator performance among middle-aged and older pilots.
  19. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression
  20. Longitudinal assessment of sleep disordered breathing in Vietnam veterans with post-traumatic stress disorder
  21. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings
  22. Aberrant parietal cortex developmental trajectories in girls with turner syndrome and related visual-spatial cognitive development: A preliminary study
  23. Comparison of the Heritability of Schizophrenia and Endophenotypes in the COGS-1 Family Study
  24. HPA axis genetic variation, cortisol and psychosis in major depression
  25. Effects of body mass index-related disorders on cognition: preliminary results
  26. Is There an Association between Advanced Paternal Age and Endophenotype Deficit Levels in Schizophrenia?
  27. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS
  28. P-values in genomics: Apparent precision masks high uncertainty
  29. Evaluating the Evidence of Replication for Genetic Associations With Schizophrenia
  30. HPA axis genetic variation, cortisol and psychosis in major depression
  31. A Genome-Wide Association Study (GWAS) for Bronchopulmonary Dysplasia
  32. Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults
  33. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression
  34. Sex Differences in Familiality Effects on Neurocognitive Performance in Schizophrenia
  35. Genome-Wide Linkage Analyses of 12 Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia
  36. Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
  37. Predischarge Screening for Severe Neonatal Hyperbilirubinemia Identifies Infants Who Need Phototherapy
  38. A Generalized Defries–Fulker Regression Framework for the Analysis of Twin Data
  39. Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms
  40. Intraindividual Variability in Basic Reaction Time Predicts Middle-Aged and Older Pilots' Flight Simulator Performance
  41. Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS)
  42. Pain sensitivity and opioid analgesia: A pharmacogenomic twin study
  43. Aversive and Reinforcing Opioid Effects
  44. Integrative Approach to Pain Genetics Identifies Pain Sensitivity Loci across Diseases
  45. Analysis of 94 Candidate Genes and 12 Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia
  46. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development
  47. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy
  48. Influences of APOE ε4 and expertise on performance of older pilots.
  49. The cost of large numbers of hypothesis tests on power, effect size and sample size
  50. Opioid Pharmacogenomics Using a Twin Study Paradigm: Methods and Procedures for Determining Familial Aggregation and Heritability
  51. Keratin Variants Predispose to Acute Liver Failure and Adverse Outcome: Race and Ethnic Associations
  52. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression
  53. Immunological response in normal healthy twins across age
  54. An  2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the  -Blocker Bucindolol in Chronic Heart Failure
  55. FKBP5 polymorphisms and antidepressant response in geriatric depression
  56. A randomized trial of computer-based reminders and audit and feedback to improve HIV screening in a primary care setting
  57. Identification of a Major Susceptibility Locus for Lethal Graft-versus-Host Disease in MHC-Matched Mice
  58. Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E
  59. Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow
  60. Physiological Correlates of Social Avoidance Behavior in Children and Adolescents With Fragile X Syndrome
  61. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study
  62. Trends in US Autism Research Funding
  63. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure
  64. Prevalence of HIV Infection Among Inpatients and Outpatients in Department of Veterans Affairs Health Care Systems: Implications for Screening Programs for HIV
  65. HIV Testing of At Risk Patients in a Large Integrated Health Care System
  66. A polymorphism within a conserved β 1 -adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
  67. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection
  68. The Effect of Diagnosis with HIV Infection on Health-Related Quality of Life
  69. The Role of a Common Adenosine Monophosphate Deaminase (AMPD)-1 Polymorphism in Outcomes of Ischemic and Nonischemic Heart Failure
  70. Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study)
  71. Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
  72. A Polymorphism in the TCF7 Gene, C883A, Is Associated With Type 1 Diabetes
  73. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations
  74. Association of IL4R Haplotypes With Type 1 Diabetes
  75. Genotype to phenotype: associations, errors and complexity
  76. CYTOMEGALOVIRUS RETINITIS AFTER INITIATION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS
  77. Allele sharing and allelic association I: Sib pair tests with increased power
  78. A chronology of fine-scale gene mapping by linkage disequilibrium
  79. Statistical refinement of primer design parameters
  80. A Conditional Inference Framework for Extending the Transmission/Disequilibrium Test
  81. Linkage Disequilibrium and Gene Mapping: An Empirical Least-Squares Approach
  82. Markov chains for Monte Carlo tests of genetic equilibrium in multidimensional contingency tables